Drug profile

The FDA adverse-event record for Amoxicillin/ Clavulanic Acid

Name: Amoxicillin/ Clavulanic Acid - FDA Animal Adverse Event Reports
Creator: PlainBreed
License: https://creativecommons.org/publicdomain/zero/1.0/

11 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Amoxicillin/ Clavulanic Acid. See the species affected, top reactions, and outcomes below.

11
adverse-event reports: 9.1%
death-coded share: Dog
most-reported species: 2
Inappropriate urination - top reaction

Compiled by PlainBreed Editorial, Pet Health Editorial Team

Verify with FDA CVM →

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

9.1%

Death Rate

Active Ingredients

Amoxicillin/ Clavulanic Acid

Administration Routes

OralUnknown

Species Affected

Dog 7

Cat 4

Most Affected Breeds

Spaniel - Cocker American 2

Domestic Longhair 2

Dachshund (unspecified) 2

Shih Tzu 1

Retriever - Labrador 1

Chartreuse 1

Domestic Shorthair 1

Chihuahua 1

Most Reported Reactions

Inappropriate urination 2

Dehydration 2

Other abnormal test result NOS 2

Ataxia 2

Blindness 2

Lymphadenopathy 1

Lymphoma 1

Death by euthanasia 1

Breathing difficulty 1

Diarrhoea 1

Falling 1

Behavioural disorder NOS 1

Outcome Breakdown

Outcome Unknown

6 (54.5%)

Recovered/Normal

4 (36.4%)

Euthanized

1 (9.1%)

Amoxicillin/ Clavulanic Acid Adverse Event Insights

11 reports name Amoxicillin/ Clavulanic Acid; 1 recorded a death outcome (9.1% of reported events, not a population-level mortality rate). Active ingredient: Amoxicillin/ Clavulanic Acid. Administration routes: Oral, Unknown.

By species: Dog (7 reports), Cat (4 reports). By breed: Spaniel - Cocker American (2), Domestic Longhair (2), Dachshund (unspecified) (2).

Leading clinical signs: Inappropriate urination (2), Dehydration (2), Other abnormal test result NOS (2), Ataxia (2). Outcome, 11 coded reports: Outcome Unknown leads at 54.5%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.